Angiotensin Receptor
The angiotensin receptors are seven-membrane G-protein-coupled receptors. They mediate the cardiovascular and other effects of angiotensin II which is a bioactive peptide of the renin–angiotensin system.
Products for Angiotensin Receptor
- Cat.No. Product Name Information
- GA20291 (Sar¹)-Angiotensin II (Sar¹)-Angiotensin II, an analogue of Angiotensin II, is a specific agonist of angiotensin AT1 receptor.
- GC17757 1H-1-ethyl Candesartan Cilexetil selective angiotensin II type 1 receptor (AT1) antagonist
- GC14445 2-Ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridine nonpeptidic angiotensin II receptor antagonist
- GC11004 A 779 angiotensin-(1-7)/ Mas receptor antagonist
- GC32674 A81988 (Abbott81988) A81988 (Abbott81988) is a potent, competitive, non-peptidic antagonist of angiotensin AT1 receptors.
- GC10146 AHU-377(Sacubitril) AHU-377(Sacubitril) (AHU-377) is a potent and orally active NEP (neprilysin) inhibitor with an IC50 of 5 nM.
-
GP10077
Angiotensin (1-7)
Ang-(1-7) (H - Asp - Arg - Val - Tyr - Ile - His - Pro - OH) is an endogenous peptide fragment that can be produced from Ang I or Ang II via endo- or carboxy-peptidases respectively[1].
- GC61496 Angiotensin (1-7) (acetate) Angiotensin 1-7 (Ang-(1-7)) acetate is an endogenous heptapeptide from the renin-angiotensin system (RAS) with a cardioprotective role due to its anti-inflammatory and anti-fibrotic activities in cardiac cells.
- GA20760 Angiotensin A (1-7) Angiotensin A (1-7), a member of the renin-angiotensin system (RAS), a vasoactive peptide, is an endogenous ligand of the G protein-coupled receptor MrgD.
- GC12671 Angiotensin Fragment 1-7 (acetate) type 1 angiotensin II receptor agonist
- GC61952 Angiotensin I/II (1-6) (TFA) Angiotensin I/II (1-6) TFA contains the amino acids 1-6 and is converted from Angiotensin I/II peptide.
-
GC35351
Angiotensin II (1-4), human
Angiotensin II (1-4), human is an endogenous peptide produced from AT I by angiotensin-converting-enzyme (ACE).
-
GC35352
Angiotensin II (3-8), human
Angiotensin II (3-8), human is a less effective agonist at the angiotensin AT1 receptor.
-
GC35353
Angiotensin II (3-8), human TFA
Angiotensin II (3-8), human (TFA) is a less effective agonist at the angiotensin AT1 receptor.
- GC42810 Angiotensin II (5-8) (human, rat, mouse) Angiotensin II (5-8) (human, rat, mouse) is an endogenous C-terminal fragment of the peptide vasoconstrictor angiotensin II.
-
GC35354
Angiotensin II 5-valine
Angiotensin II 5-valine is an agonist of angiotensin receptor.
-
GC60584
Angiotensin II human acetate
Angiotensin II human (Angiotensin II) acetate is a vasoconstrictor and a major bioactive peptide of the renin/angiotensin system.
-
GC62844
Angiotensin II human TFA
Angiotensin II human (Angiotensin II) TFA is a vasoconstrictor and a major bioactive peptide of the renin/angiotensin system.
- GC35355 Angiotensin III
- GP10110 Angiotensin III (human, mouse) An agonist at AT1 and AT2 receptors
- GC35356 Angiotensin III TFA
- GC66025 Angiotensin III, human, mouse TFA Angiotensin III, human, mouse (TFA) is an angiotensin.
- GC12065 AVE 0991 AVE 0991 is a Nonpeptide Mimic of the Effects of Angiotensin-(1-7) on the Endothelium.
- GC17686 AVE 0991 sodium salt Ang-(1-7) receptor Mas agonist
- GC13277 Azilsartan Potent angiotensin II type 1 (AT1) receptor inverse agonist
- GC35452 Azilsartan D5 Azilsartan D5 (TAK-536 D5) is the deuterium labeled Azilsartan(TAK-536), which is a specific and potent angiotensin II type 1 receptor antagonist.
-
GC11407
Azilsartan Medoxomil
Angiotensin II receptor type 1 antagonist
-
GC10642
Azilsartan medoxomil monopotassium
Angiotensin II receptor type 1 antagonist
- GC66468 Azilsartan mepixetil Azilsartan mepixetil is the antagonist of angiotensin II receptor. Azilsartan mepixetil has stronger and longer blood pressure effect, more abvious and longer lasting heart rate lowering effect and high safety. Azilsartan mepixetil achieves ideal protective effect for heart and kidney functions. Azilsartan mepixetil has the potential for the research of hypertension, chronic heart failure and diabetic nephropathy (extracted from patent CN107400122A).
- GC66440 Azilsartan mopivabil Azilsartan mopivabil is the potent antagonist of angiotensin II receptor.
- GC46913 Benazepril-d5 (hydrochloride) An internal standard for the quantification of benazapril
- GC19071 BIBS 39 BIBS 39 is a new nonpeptide angiotensin II (AII) receptor antagonist.
- GC60095 Brain Natriuretic Peptide (1-32), rat acetate Brain Natriuretic Peptide (1-32), rat acetate (BNP (1-32), rat acetate) is a 32 amino acid polypeptide secreted by the ventricles of the heart in response to excessive stretching of heart muscle cells (cardiomyocytes).
- GC32589 Brain Natriuretic Peptide (BNP) (1-32), rat Brain Natriuretic Peptide (BNP) (1-32), rat (BNP (1-32), rat) is a 32 amino acid polypeptide secreted by the ventricles of the heart in response to excessive stretching of heart muscle cells (cardiomyocytes).
- GC12034 C-type natriuretic peptide (1-22) (human, rat, swine) C-type natriuretic peptide (1-22) (human, rat, swine), a 1-22 fragment of CNP, is a natriuretic peptide receptor B (NPR-B) agonist.
- GC35756 C-Type Natriuretic Peptide (1-53), human C-Type Natriuretic Peptide (1-53), human is the 1-53 fragment of C-Type Natriuretic Peptide.
-
GC68908
C-Type Natriuretic Peptide (1-53), human TFA
C-Type Natriuretic Peptide (1-53), human TFA is a fragment of C-type natriuretic peptide consisting of amino acids 1 to 53. C-Type Natriuretic Peptide TFA belongs to the family of natriuretic peptides and is involved in maintaining electrolyte-fluid balance and vascular tone.
- GC16978 Candesartan Angiotensin II receptor 1 (AT1) antagonist
- GC12318 Candesartan Cilexetil Prodrug of the angiotensin II receptor 1 (AT1) antagonist candesartan
- GC40238 Candesartan-d4 Candesartan-d4 is intended for use as an internal standard for the quantification of candesartan by GC- or LC-MS.
- GC15406 CGP 42112 angiotensin AT2 receptor ligand
- GC32561 CGP48369 CGP48369 is a nonpeptidic angiotensin II receptor antagonist, used for anti-hypertensive research.
- GC60748 Dehydro Olmesartan Dehydro Olmesartan is a derivative of Olmesartan.
- GC43580 DX600 DX600 is a potent and selective peptide inhibitor of angiotensin-converting enzyme 2 (ACE2; Kis = 2.8, 200, and 1,200 nM for recombinant, human, and murine ACE2, respectively).
- GC49566 DX600 (trifluoroacetate salt) A peptide inhibitor of ACE2
- GC32536 Elisartan (HN 65021) Elisartan (HN 65021) is an orally active non-peptide pro-drug of angiotensin II AT1 receptor antagonist HN-12206, and shows anti-hypertension activities.
- GC19137 EMA401 EMA401 (EMA401) is a highly selective, orally active, peripherally restricted angiotensin II type 2 receptor (AT2R) antagonist.
- GC13436 EMD 66684 angiotensin AT1 receptor antagonist
- GC16297 Eprosartan Mesylate Angiotensin AT1 receptor antagonists
- GC36046 Fimasartan Fimasartan(BR-A-657) is a non-peptide angiotensin II receptor antagonist used for the treatment of hypertension and heart failure.
- GC47371 Fosinopril-d7 (sodium salt) An internal standard for the quantification of fosinopril
- GC49228 Ganoderol B A triterpenoid with diverse biological activities
- GC31529 H-Val-Pro-Pro-OH H-Val-Pro-Pro-OH, a milk-derived proline peptides derivative, is an inhibitor of Angiotensin I converting enzyme (ACE), with an IC50 of 9 μM.
- GC34326 H-Val-Pro-Pro-OH TFA H-Val-Pro-Pro-OH (TFA), a milk-derived proline peptides derivative, is an inhibitor of Angiotensin I converting enzyme (ACE), with an IC50 of 9 μM.
- GC10467 Irbesartan Angiotensin II inhibitor
- GC40208 Irbesartan-d4 Irbesartan-d4 is intended for use as an internal standard for the quantification of irbesartan by GC- or LC-MS.
- GC32569 L-159282 (MK 996) L-159282 (MK 996) is a highly potent, orally active, nonpeptide angiotensin II receptor antagonist, with anti-hypertensive activity.
- GC30443 L162389 L162389 is a potent antagonist of angiotensin AT1 receptor with Ki of 28 nM.
- GC31567 L162441 L162441 is an Angiotensin type 1 receptor antagonist.
- GC11784 LCZ696 LCZ696 (LCZ696), comprised Valsartan and Sacubitril (AHU377) in 1:1 molar ratio, is a first-in-class, orally bioavailable, and dual-acting angiotensin receptor-neprilysin (ARN) inhibitor for hypertension and heart failure.
- GC45501 Lisinopril-d5
-
GC10249
Losartan
Angiotensin II receptor antagonist
- GC12512 Losartan Carboxylic Acid AT1 antagonist
- GC36480 Losartan D4 An internal standard for the quantification of losartan
- GC36481 Losartan D4 Carboxylic Acid Losartan D4 Carboxylic Acid (E-3174 D4) is the deuterium labeled Losartan(EXP-3174), which is an angiotensin II receptor antagonist.
- GC10257 Losartan Potassium (DuP 753) Losartan Potassium (DuP 753) (DuP-753 potassium) is an angiotensin II receptor type 1 (AT1) antagonist, competing with the binding of angiotensin II to AT1 with an IC50 of 20 nM.
- GC32632 LY285434 LY285434 is a suitable angiotensin II receptor antagonist.
- GC64604 Mopivabil Mopivabil is the antagonist of angiotensin II receptor.
- GC10024 Novokinin Angiotensin AT2 receptor agonist
- GC16936 Olmesartan An AT1 receptor antagonist and active metabolite of olmesartan medoxomil
- GC36802 Olmesartan D4 Olmesartan D4 (RNH-6270 D4) is the deuterium labeled Olmesartan.
- GC16752 Olmesartan medoxomil A prodrug form of olmesartan
- GC61153 Olmesartan medoxomil impurity C Olmesartan medoxomil impurity C is an Olmesartan medoxomil impurity.
- GC61154 Olmesartan methyl ester Olmesartan methyl ester is an intermediate in the synthesis of Olmesartan medoxomil.
- GC17384 PD 123319 ditrifluoroacetate A selective angiotensin II type 2 receptor antagonist
-
GC16394
PD123319
PD123319 is a non-peptide inhibitor of angiotensin II receptor with IC50 value of 34nM .
- GC16871 Perindopril ACE inhibitor
- GC32530 Pratosartan (FW 7203) Pratosartan (FW 7203) is a selective angiotensin II receptor antagonist.
- GC48513 Quinapril-d5 An internal standard for the quantification of quinapril
- GC49653 Ramipril Diketopiperazine A potential impurity found in commercial preparations of ramipril
- GC49408 Ramipril Diketopiperazine Acid A potential impurity found in commercial preparations of ramipril
- GC39821 Saralasin TFA Saralasin ([Sar1,Ala8] Angiotensin II) TFA is an octapeptide analog of angiotensin II.
- GC32591 SL910102 SL910102 is a nonpeptide angiotensin AT1 receptor antagonist.
- GC32479 Sparsentan (RE-021) Sparsentan (RE-021) (RE-021) is a highly potent dual angiotensin II and endothelin A receptor antagonist with Kis of 0.8 and 9.3 nM, respectively.
- GC32507 Tasosartan (WAY-ANA 756) Tasosartan (WAY-ANA 756) is a long-acting angiotensin II (AngII) receptor antagonist.
- GC38856 TD-0212 TFA TD-0212 TFA is an orally active dual pharmacology angiotensin II type 1 receptor (AT1) antagonist and neprilysin (NEP) inhibitor, with a pKi of 8.9 for AT1 and a pIC50 of 9.2 for NEP.
- GC15023 Telmisattan Telmisattan is a potent, long lasting antagonist of angiotensin II type 1 receptor (AT1), selectively inhibiting the binding of 125I-AngII to AT1 receptors with IC50 of 9.2 nM.
- GC18202 Temocaprilat An ACE inhibitor
- GC46233 Trandolaprilat (hydrate) Trandolaprilat (hydrate) is a potent angiotensin-converting enzyme (ACE) inhibitor.
- GC13389 Tranilast Angiogenesis inhibitor
- GC12443 Tranilast Sodium Antiallergic agent
- GC37819 trans-Tranilast trans-Tranilast (trans-MK-341) is an antiallergic drug, used to treat bronchial asthma, allergic rhinitis and atopic dermatitis.
-
GC70070
TRV-120027
TRV120027 is a β-arrestin-1 agonist for angiotensin II type 1 receptor (AT1R). TRV120027 induces acute catecholamine secretion through coupling with the cation channel subfamily C3 (TRPC3), promoting the formation of a large molecular complex consisting of AT1R-β-arrestin-1-TRPC3-PLCγ on the plasma membrane. TRV120027 inhibits angiotensin II-mediated vasoconstriction and increases myocardial contractility. It has potential for use in research on acute decompensated heart failure (ADHF).
-
GC70068
TRV055
TRV055 is a G protein-biased agonist that selectively targets the type 1 angiotensin II receptor (AT1R) through Gq signaling. It effectively stimulates intracellular signal transduction mediated by Gq.
- GC67768 TRV055 hydrochloride
-
GC70069
TRV056
TRV056 is a ligand for the Gq-biased type 1 angiotensin II receptor (AT1R). TRV056 effectively stimulates cell signaling mediated by Gq. TRV056 can be used to develop Gq-biased AT1R agonists.
-
GC10765
Valsartan
Angiotensin II AT1 receptor antagonist
- GC37884 Valsartan D9 Valsartan D9 (CGP 48933-d9) is deuterium labeled valsartan.
- GC37954 YS-49 YS-49 is a PI3K/Akt (a downstream target of RhoA) activator, to reduce RhoA/PTEN activation in the 3-methylcholanthrene-treated cells.
- GC37955 YS-49 monohydrate YS-49 (monohydrate) is a PI3K/Akt (a downstream target of RhoA) activator, to reduce RhoA/PTEN activation in the 3-methylcholanthrene-treated cells.